Merck & Company Inc
Stock Chart, Company Information, and Scan Results
$100.89(as of Dec 4, 4:00 PM EST)
Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.
Merck & Company Inc Company Information, Fundamentals, and Technical Indicators
Stock Price$100.89
Ticker SymbolMRK
ExchangeNyse
SectorHealthcare
IndustryDrug Manufacturers - General
Employees73,000
CountyUSA
Market Cap$255,448.3M
EBIDTA31,523.0M
10-Day Moving Average101.43
P/E Ratio13.24
Forward P/E Ratio10.83
Earnings per Share7.65
Profit Margin33.49%
RSI63.85
Shares Outstanding2,482.0M
ATR2.71
52-Week High105.84
Volume12,769,285
52-Week Low71.87
Book Value51,907.0M
P/B Ratio4.86
Upper Keltner102.38
P/S Ratio3.92
Lower Keltner90.19
Debt-to-Equity Ratio102.38
Next Earnings Date02/03/2026
Cash Surplus-10,459.0M
Next Ex-Dividend Date12/15/2025
This pharmaceutical company is responsible for one of the best-selling drugs worldwide. Their blockbuster drug, Keytruda, is designed to treat certain types of cancer and is the company’s main revenue driver. They are also behind the development of Gardasil—a vaccine for HPV that has helped prevent hundreds of thousands of cases of cervical cancer.
Merck & Company Inc In Our Stock Scanner
As of Dec 05, 2025
Scan Name: Uptrending StocksScan Type: Chart Pattern Scans
As of ---
Scan Name: Increasing Profit MarginScan Type: Stock Fundamentals
As of ---
Scan Name: Undervalued Blue ChipsScan Type: Stock Fundamentals
As of ---
Scan Name: Increasing Book ValueScan Type: Stock Fundamentals
As of ---
Scan Name: Undervalued StocksScan Type: Stock Fundamentals
As of ---
Join Our Free Email List
Get emails from us about ways to potentially make money in the stock market.